title: [Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease?].
abstract: BACKGROUND
  Non-alcoholic fatty liver disease (NAFLD) is frequently diagnosed in daily practice. This condition is represented by a large spectrum of chronic liver diseases going from pure hepatic steatosis to cirrhosis and its complications, including hepatocellular carcinoma. NAFLD is usually associated to glucose and lipoproteins metabolism increasing the cardiovascular risk.
  
  
  OBJECTIVE
  To review new advances in the knowledge of the pathophysiological links between NAFLD and cardiovascular risk, evaluation of cardiovascular risk in this special situation and the different therapeutics proposed.
  
  
  METHODS
  Systematic review of the literature using medical data bases (Medline) with the following key words: non-alcoholic fatty liver disease, hepatic steatosis, cardiovascular risk, metabolic syndrome.
  
  
  RESULTS
  We'll report pathophysiological links between NAFLD and cardiovascular risk, propose an evaluation of cardiovascular risk in this special situation and expose a therapeutic strategy.
  
  
  CONCLUSIONS
  The discovery of a non alcoholic fatty liver disease should lead to a cardiovascular risk evaluation.
authors.forename: Wissem
authors.initials: W
authors.lastname: Sdiri
authors.forename: Hayfa
authors.initials: H
authors.lastname: Romdhane
authors.forename: Dorra
authors.initials: D
authors.lastname: Mbarek
authors.forename: Hatem
authors.initials: H
authors.lastname: Ben Abdallah
authors.forename: Selma
authors.initials: S
authors.lastname: Longo
authors.forename: Mohamed Nabil
authors.initials: MN
authors.lastname: Abdelli
authors.forename: Mohamed Rachid
authors.initials: MR
authors.lastname: Boujnah
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology*; D005234:Fatty Liver / Q000150:complications*; D006801:Humans; D012307:Risk Factors